People with inflammatory bowel disease may benefit from a new experimental treatment in which tissues are treated with siRNA thioketal nanoparticles (new polymer -- poly-(1,4-phenyleneacetone dimethylene thioketal) (PPADT) PPADT siRNA that inhibits an inflammation-promoting cytokine called tumor necrosis factor -- alpha (TNF-α).
References:
Georgia Institute of Technology. siRNA delivery system to treat inflammatory bowel diseases developed.
No comments:
Post a Comment